TAS-102: A resurrected novel Fluoropyrimidine with expanding role in the treatment of gastrointestinal malignancies

Chakrabarti, S; Wintheiser, G; Tella, SH; Oxencis, C; Mahipal, A

Mahipal, A (corresponding author), Mayo Clin, Dept Oncol, 200 1st St SW, Rochester, MN 55906 USA.

PHARMACOLOGY & THERAPEUTICS, 2021; 224 ():

Abstract

TAS-102 is an orally administered fixed-dose formulation consisting of trifluorothymidine (TFT), a fluoropyrimidine antimetabolite, and tipiracil (TPI......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索